G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
GMVD was delisted on the 23rd of August, 2023.
14 hedge funds and large institutions have $162K invested in G Medical Innovations Holdings Ltd. Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
71% less capital invested
Capital invested by funds: $551K → $162K (-$389K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
S
swisspartners
Vaduz,
Liechtenstein
|
+$71.4K |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$43K |
| 3 |
Jane Street
New York
|
+$19.3K |
| 4 |
VF
Virtu Financial
New York
|
+$18.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$13.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Regal Partners
Sydney, NSW,
Australia
|
-$322K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
-$22.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$15K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$7K |
| 5 |
Citigroup
New York
|
-$7K |
GMVD Hedge Fund Activity: Q3 2022 in Review
14 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) for Q3 2022, worth a combined $162K — down 71% from $551K a quarter earlier.
Fund positioning in GMVD was balanced in Q3 2022: 5 funds opened new positions, 5 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was swisspartners, opening a new position worth an estimated $71.4K. The largest seller was Regal Partners, exiting entirely with an estimated $322K sold.
- 14 institutional investors held G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $162K of G Medical Innovations Holdings Ltd. Ordinary Shares stock for Q3 2022, down 71% quarter-over-quarter.
- 5 funds opened new G Medical Innovations Holdings Ltd. Ordinary Shares positions in Q3 2022 and 5 closed out, a net change of 0 holders.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares buyer in Q3 2022 was swisspartners, an estimated $71.4K added.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares seller in Q3 2022 was Regal Partners, an estimated $322K sold.
Based on aggregated 13F filings for Q3 2022.